Schwann cell development, differentiation and myelination

Current Opinion in Neurobiology

Volumn 6, Issue 1, 1996, Pages 89-96

  Mirsky, Rhona ^a   Jessen, Kristján R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEURITE PROMOTING FACTOR; TETRASPAN; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL MATURATION; CELL POLARITY; GENETIC TRANSCRIPTION; MOUSE; MYELINATION; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHWANN CELL; STEM CELL;

EID: 0029971794     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(96)80013-4     Document Type: Article

References (70)

1. Paul DL: New functions for gap junctions. Curr Opin Cell Biol 1995, 7:665-672. A review of the significance of mutations in gap junction proteins in human disease. Of particular relevance is the discussion of the role of connexin 32 in X-linked Charcot-Marie-Tooth neuropathy. The review also includes a diagram of the location of connexin 32 in myelin-forming Schwann cells.
2. Filbin MT: Myelin-associated glycoprotein: a role in myelination and in the inhibition of axonal regeneration. Curr Opin Neurobiol 1995, 5:588-595. Comprehensive review of work on the role of MAG in myelination and in either promoting or inhibiting regeneration, as well as covering recent work on MAG knock-outs.
3. Rickman M, Fawcett JW, Keynes RJ: The migration of neural crest cells and the growth of motor axons through the rostral half of the chick somite. J Embryol Exp Morphol 1985, 90:437-455.
4. Loring JF, Erickson CA: Neural crest pathways in the trunk of the chick embryo. Dev Biol 1987, 121:220-236.
5. Bhattacharyya A, Brackenbury R, Ratner N: Axons arrest the migration of Schwann cell precursors. Development 1994, 120:1411-1420. When the ventral neural tube in chicks is ablated, neural crest cells migrate normally towards the region of the ventral root. Therefore, ventral motor neurons are not essential for ventral and ventrolateral migration of neural crest cells.
6. Shah NM, Marchionni MA, Isaacs I, Stroobant P, Anderson DJ: Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 1994, 77:349-360. Addition of NDF (glial growth factor) to clonal cultures of rat neural crest cells grown in a complex medium reduces the number of clones containing neurons and glia, and increases the number of clones containing glia only. This study indicates that NDF acts as an instructive signal, making a neural fate less likely and a glial fate more likely.
7. Ben-Baruch N, Yarden Y: Neu differentiation factors: a family of alternatively spliced neuronal and mesenchymal factors. Proc Soc Exp Biol Med 1994, 206:221-227.
8. Marchionni MA, Goodearl ADJ, Chen MS, Bermingham-McDonogh O, Kirk C, Hendricks M, Danehy F, Misumi D, Sudhalter J, Kobayashi K et al.: Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 1993, 362:312-318.
9. ••]).
10. 0 is an early marker of the Schwann cell lineage in chickens. Neuron 1991, 7:831-844.
11. 0 is expressed at early stages of chicken and rat embryogenesis. J Neurosci Res 1995, 40:241-250.
12. Jessen KR, Brennan A, Morgan L, Mirsky R, Kent AR, Hashimoto Y, Gavrilovic J: The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves. Neuron 1994, 12:509-527. Identification and characterization of the Schwann cell precursor, a novel cell in the Schwann cell lineage, which differs from Schwann cells in a number of apparently unrelated phenotypic features. Immature Schwann cells are generated from precursor cells between E14/E15 and E17/E18.
13. Gavrilovic J, Brennan A, Mirsky R, Jessen KR: Fibroblast growth factors and insulin growth factors combine to promote survival of rat Schwann cell precursors without induction of DNA synthesis. Eur J Neurosci 1995, 7:77-85.
14. •]).
15. Levi AD, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, Sliwkowski MX: The influence of heregulins on human Schwann cell proliferation. J Neurosci 1995, 15:1329-1340.
16. Rutkowski JL, Kirk CJ, Lerner MA, Tennekoon GI: Purification and expansion of human Schwann cells in vitro. Nature Med 1995, 1:80-83. Schwann cells cultured from human peripheral nerves proliferate in response to human NDF, and cAMP synergizes with NDF to promote Schwann cell proliferation and suppress fibroblast growth over several passages in culture. Thus, large numbers of cells can be obtained from human nerve biopsies (see also [15]).
17. Thoenen H: The changing scene of neurotrophic factors. Trends Neurosci 1991, 14:165-170.
18. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simpson LC, Moffet B, Vandlen RA, Koliatsos VE et al.: GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994, 266:1062-1064.
19. Topilko P, Schneider-Manoury S, Levi G, Baron-Van Evercooren A, Chennoufi ABY, Seitanidou T, Babinet C, Charney P: Krox-20 controls myelination in the peripheral nervous system. Nature 1994, 371:796-799. Krox-20 knock-out mouse with a lacZ insert shows that Krox-20 expression is strongly activated at the time when precursors generate Schwann cells and that, in the absence of Krox-20, Schwann cells ensheath axons but do not myelinate them.
20. 0 promoter show both an early onset of myelination and hypermyelination. It is suggested that Oct-6 serves to repress myelin genes during late embryonic development; however, other interpretations are possible.
21. 0 gene by the POU transcription factor SCIP. Mech Dev 1993, 42:15-32.
22. Herr W, Cleary MA: The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev 1995, 9:1679-1693.
23. Kioussi C, Gross MK, Gruss P: Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 1995, 15:553-562. Pax-3 mRNA is present in non-myelin-forming postnatal mouse Schwann cells but not in cells that express the myelin protein MBP. Microinjection of Pax-3 expression vector results in downregulation of MBP. Elevation of cAMP, which stimulates myelin differentiation, suppresses endogenous Pax-3 expression. These experiments implicate Pax-3 as a negative regulator of myelination.
24. Monuki ES, Weinmaster G, Kuhn R, Lemke G: SCIP: a glia POU domain gene regulated by cyclic AMP. Neuron 1989, 3:783-793.
25. De Felipe C, Hunt SP: The differential control of c-Jun expression in regenerating sensory neurones and their associated glial cells. J Neurosci 1994, 14:2911-2923,
26. Stewart HJS: Expression of c-Jun, Jun B, Jun D and cAMP response element binding protein by Schwann cells and their precursors in vivo and in vitro. Eur J Neurosci 1995, 7:1366-1375.
27. 0 promoter, and T antigen and c-Jun form a complex that can be co-precipitated with antibodies. The authors suggest that a similar mechanism of repression might operate to produce hypomyelination and demyelination in certain mouse transgenic and human peripheral neuropathies.
28. Jessen KR, Mirsky R: Schwann cells: early lineage, regulation of proliferation and control of myelin formation. Curr Opin Neurobiol 1992, 2:575-581.
29. 0 mRNA and protein induction in cultured Schwann cells by FGF2 and TGFβ1, TGFβ2 and TGFβ3. Development 1994, 120:1399-1409.
30. LeBlanc AC, Poduslo JF: Axonal modulation of myelin gene expression in the peripheral nerve. J Neurosci Res 1990, 26:317-326.
31. 0 expression and DNA synthesis by insulin-like growth factors in vitro. Eur J Neurosci 1996, in press.
32. Kerkhoff H, Hassan SM, Troost D, Van Etten RW, Veldmann H, Jennekens FGI: Insulin-like and fibroblast growth factors in spinal cords, nerve roots and skeletal muscle of human controls and patients with amyotrophic lateral sclerosis. Acta Neuropathol 1994, 87:411-421.
33. 0 mRNA expression and down-regulation of the low-affinity NGF receptor. Glia 1993, 8:208-217.
34. 0 induction in response to cAMP and induces upregulation of NCAM (neural cell adhesion molecule).
35. 0, galactocerebroside, MAG and MBP expression are blocked, while GFAP expression is markedly increased. Ensheathment of axons is typical of that seen in mature non-myelinated nerves.
36. Stewart HJS, Rougon G, Dong Z, Dean C, Jessen KR, Mirsky R: TGF-βs upregulate NCAM and L1 expression in cultured Schwann cells, suppress cyclic AMP-induced expression of 04 and galactocerebroside, and are widely expressed in cells of the Schwann cell lineage in vivo. Glia 1995, 15:419-436.
37. Rufer M, Flanders K, Unsicker K: Presence and regulation of transforming growth factor beta mRNA and protein in the normal and lesioned rat sciatic nerve. J Neurosci Res 1994, 39:412-423.
38. Scherer SS, Kamholz J, Jakowlew SB: Axons modulate the expression of transforming growth factor-betas in Schwann cells. Glia 1993, 8:265-276.
39. Schluesener HJ, Meyermann R, Jung S: Immunolocalization of vgr (BMP-6, DVR-6), a TGF-β-related cytokine, to Schwann cells of the rat peripheral nervous system: expression patterns are not modulated by autoimmune disease. Glia 1995, 13:75-78.
40. Koenig HL, Schumacher M, Ferzaz B, Do Thi AN, Ressouches A, Guennoun R, Jung-Testas I, Robel P, Akwa Y, Baulieu E-E: Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500-1503. Evidence for a role for progesterone in myelination. Inhibition of progesterone synthesis or block of its action in Schwann cells results in hypomyelination in regenerating nerves, whereas administration of progesterone or its precursor enhances myelination in regenerating nerves and in co-cultures of myelinating Schwann cells and neurons.
41. Krasnoselsky A, Massay MJ, DeFrances MC, Michalopoulos G, Zarnegar R, Ratner N: Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas. J Neurosci 1994, 14:7284-7290.
42. Cheng L, Khan M, Mudge AW: Calcitonin gene-related peptide promotes Schwann cell proliferation. J Cell Biol 1995, 129:789-796.
43. Gould RM, Byrd AL, Barbarese E: The number of Schmidt-Lanterman incisures is more than doubled in shiverer PNS myelin sheaths. J Neurocytol 1995, 24:85-98.
44. Fruttiger M, Montag D, Schachner M, Martini R: Crucial role for the myelin-associated glycoprotein in the maintenance of axonal-myelin integrity. Eur J Neurosci 1995, 7:511-515. In many of the older MAG knock-out mice, some myèlinated fibres in the PNS show demyelination and axonal degeneration. The results suggest that MAG has an important role in maintaining the relationship between axonal and inner Schwann cell membranes.
45. Suter U, Snipes GJ: Peripheral myelin protein 22: facts and hypotheses. J Neurosci Res 1995, 40:145-151.
46. 0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J Neurosci 1995, 15:4488-4495.
47. Bunge RP: Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration. Curr Opin Neurobiol 1993, 3:805-809.
48. 4 subunit J Cell Sci 1994, 107:543-552.
49. 4 rise (see [48,50,51]).
50. Einheber S, Milner T, Giancotti F, Salzer J: Axonal regulation of Schwann cell integrin expression suggests a role for alpha6 beta4 in myelination. J Cell Biol 1993, 123:1223-1236.
51. 4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent Development 1994, 120:1287-1301.
52. Fannon AM, Sherman DL, Ilyina-Gragerova G, Brophy PJ, Friedrich VL Jr, Colman DR: Novel E-cadherin-mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. J Cell Biol 1995, 129:189-202. Confocal and immunoelectronmicroscopy show that E-cadherin, F-actin and β-catenin are concentrated in adherens-type junctions in myelin-forming Schwann cells. It is suggested that these junctions are essential components of the Schwann cell cytoplasmic channel network. A related study [53] has found E-cadherin in non-myelin-forming Schwann cells and satellite cells at sites of membrane-membrane and membrane-basal-lamina interaction.
53. Uchiyama N, Hasegawa M, Yamashima T, Yamashita J, Shimamura K, Takeichi M: Immunoelectron microscopic localization of E-cadherin in dorsal root ganglia, dorsal root and dorsal horn of postnatal mice. J Neurocytol 1994, 23:460-468.
54. Gillespie CS, Sherman DL, Blair GE, Brophy PJ: Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment Neuron 1994, 12:497-508.
55. Scherer SS, Xu YT, Bannerman P, Sherman DL, Brophy PJ: Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development Development 1995, 121:4265-4273.
56. 2+ levels. It is suggested that the antibodies mimic the natural ligand of CD9 (see also [57,58,64]).
57. Hadjiargyrou M, Patterson PH: An anti-CD9 monoclonal antibody promotes adhesion and induces proliferation of Schwann cells in vitro. J Neurosci 1995, 15:574-583.
58. Kaprielian Z, Cho KO, Hadjiargyrou M, Patterson PH: CD9, a major platelet cell surface glycoprotein, is a ROCA antigen and is expressed in the nervous system. J Neurosci 1995, 15:562-573.
59. Spreyer P, Kuhn G, Hanemann CO, Gillen C, Schaal H, Kuhn R, Lemke G, Müller HW: Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth-arrest-specific' gene. EMBO J 1991, 10:3661-3668.
60. Fischer I, Sapirstein VS: Molecular cloning of plasmolipin. J Biol Chem 1994, 269:24912-24919.
61. Gillen C, Gleichmann M, Greiner-Petter R, Zoidl G, Kupfer S, Bosse F, Auer J, Müller HW: Full length cloning, expression and cellular localization of rat plasmolipin mRNA, a proteolipid of PNS and CNS. Eur J Neurosci 1996, 8:405-414.
62. Schaeren-Wiemers N, Valenzuela DM, Frank M, Schwab ME: Characterization of a rat gene, rMAL, encoding a protein with four hydrophobic domains in central and peripheral myelin. J Neurosci 1995, 15:5753-5764.
63. Nave KA: Neurological mouse mutants and the genes of myelin. J Neurosci Res 1994, 38:607-612.
64. Tole S, Patterson PH: Distribution of CD9 in the developing and mature rat nervous system. Dev Dyn 1993, 197:94-106.
65. Bosse F, Zoidl G, Wilms S, Gillen CP, Kuhn HG, Müller HW: Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination. J Neurosci Res 1994, 37:529-537.
66. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Müller HW: Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J 1995, 14:1122-1128. This paper tests the theory that PMP22 might be involved in growth arrest by using retroviruses to overexpress PMP22 in Schwann cells and fibroblasts. In Schwann cells overexpressing PMP22, entry of quiescent cells into the cell cycle is significantly delayed, providing some evidence to support this theory.
67. Parmantier E, Cabon F, Braun C, D'Urso D, Müller HW, Zalc B: Peripheral myelin protein-22 is expressed In rat and mouse brain and spinal cord motoneurons. Eur J Neurosci 1995, 7:1080-1088.
68. Hosoya T, Takizawa K, Nitta K, Hotta Y: glial cells missing: a binary switch between neuronal and glial determination in Drosophila. Cell 1995, 82:1025-1036.
69. Jones BW, Fetter RD, Tear G, Goodman CS: glial cells missing: a genetic switch that controls glial versus neuronal fate. Cell 1995, 82:1013-1023.
70. Meyer D, Birchmeier C: Multiple essential functions of neuregulin in development. Nature 1995, 378:386-390. Mice deficient in neuregulin die of heart abnormalities at embryo day 11 and Schwann cell precursors and cranial ganglia fail to develop normally, highlighting the importance of neuregulins in peripheral nervous system development.